Thu, Aug 21, 2014, 6:13 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Amedica Corporation Message Board

  • dragan7777777777 dragan7777777777 Feb 23, 2014 9:11 PM Flag

    Instead of asking questions do some DD.....

    Instead of asking questions do some DD. Here is for the start:

    AMDA is the only firm using a silicon nitride technology platform for medical applications. Silicon nitride bio-material promotes bone growth, hardness, and strength; resists wear; and has anti-infective properties that AMDA believes other commonly used bio-materials, like polyetheretherketone, cannot match. The firm also offers complementary non-silicon nitride spinal fusion products, which accounted for approximately 70% of AMDA's revenues in calendar 2011 and 2012. AMDA operates a 30,000 square foot manufacturing facility in Salt Lake City.

    Valuation
    AMDA offers the following figures in its S-1 balance sheet for the nine months ending September 30, 2013:

    Revenue: $16,603,662.00
    Net Loss: ($8,948,291.00)
    Total Assets: $35,569,104.00
    Total Liabilities: $28,009,394.00
    Stockholders' Equity: ($153,896,102.00)

    Amedica is a simple story. If you believe Silicon Nitride is the next "bio-material" solving the infection issues surrounding titanium implants, the stock will be acquired for a meaningful amount of money. The looses are attributed to core research in what is already approved by the FDA in spine implants. This is a biomaterial, technology play.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Dragan,

      Good info. I have been involved with the company as an investor for many years so one quick important correction to your blurb.
      The company doesn't just "believe" those properties of silicon nitride can't be matched. There was clinical testing by third parties at Brown University, which data was published in peer reviewed research publications, that showed UNQUESTIONABLY that their materials promote bone on bone growth, and repel infection far better than any alternative standard of care.

      Those are facts and bode very well for the long term adoption of Silicon Nitride by the industry. Post operative infection is a MAJOR problem right now and Amedica is the answer.

      All FYI

      Sentiment: Strong Buy

    • Sorry that was suppose to be a thumbs up...not thumbs down...and it won't let me change it...

 
AMDA
2.80+0.01(+0.36%)Aug 21 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.